Huahai Pharmaceutical announces convertible bond conversion results

Zhejiang Huahai Pharmaceutical (SSE:600521) announced the results of its convertible bond ("Huahai Convertible Bonds") conversion. From January 1, 2025, to March 31, 2025, CNY 4,000 of bonds were converted into 117 shares, representing a negligible 0.000008% of the company's pre-conversion share capital. Cumulatively, CNY 182,000 of bonds have been converted into 5,304 shares, or 0.00036% of the pre-conversion share capital. As of March 31, 2025, CNY 1,842,417,000 of Huahai Convertible Bonds remain unconverted, representing 99.9901% of the total issuance. The conversion price is currently CNY 33.21 per share, adjusted after a prior private placement.